test

Neb Obradovic

@Cormorant Asset Management, Lp

Latest period2024 - Q3ReportedManaged Assets$1.886BTotal holdings45
Assets growth rate8.94%Assets growth rate (2-Q avg)-7.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Cormorant Asset Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 45 positions.

Assets under management

The assets under management (AUM) of Cormorant Asset Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.886B in assets, with a quarterly growth rate of 8.94% and a 2-quarter average growth rate of -7.56%. The portfolio is managed by Neb Obradovic, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
EWTXEdgewise Therapeutics Inc
Recent Activity
Increased 13.31%
4.83%
$90.92M
3.407M shares@ $26.69 avg price
RAPPRapport Therapeutics Inc
Recent Activity
Increased 0.03%
3.2%
$60.23M
2.941M shares@ $20.48 avg price
PRAXPraxis Precision Medicines I
Recent Activity
Increased 27.01%
2.66%
$50.06M
870,000 shares@ $57.54 avg price
CRBPCorbus Pharmaceuticals Hldgs
Recent Activity
Increased 17.29%
2.6%
$48.996M
2.375M shares@ $20.63 avg price
RNAAvidity Biosciences Inc
Recent Activity
Increased 147.06%
2.56%
$48.226M
1.05M shares@ $45.93 avg price
NAMSNewamsterdam Pharma Company
Recent Activity
Increased 7.4%
2.18%
$41.002M
2.47M shares@ $16.6 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
Increased 58.95%
2.18%
$40.96M
2.562M shares@ $15.99 avg price
AVBPArrivent Biopharma Inc
Recent Activity
Increased 13.69%
0.73%
$13.758M
585,462 shares@ $23.5 avg price